Combining targeted therapy with immunotherapy (interferon-α): Rational, efficacy in gastrointestinal stromal tumor model and implications in other malignancies

Imatinib revolutionized gastrointestinal stromal tumor (GIST) treatment but median-progression-free-survival of unresectable/metastatic disease is < 2 y. B-RAF(V600)-mutated-melanoma responds to vemurafenib dramatically but median-progression-free-survival is < 9 mo. Combining imatinib with im...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chen, Lei L., Gouw, Launce, Sabripour, Mahyar, Hwu, Wen-Jen, Benjamin, Robert S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2012
Gaiak:
Author's View
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3429591/
https://ncbi.nlm.nih.gov/pubmed/22934279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.19729
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak